Trial Profile

A trial to investigate middle-east respiratory syndrome coronavirus vaccine for compassionate use

Status: Planning

Phase of Trial: Clinical Phase Unknown

Latest Information Update: 29 Dec 2014

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Middle-East respiratory syndrome coronavirus vaccine Organic Vaccines (Primary)
Indications Middle East respiratory syndrome coronavirus
Focus Therapeutic Use

Most Recent Events

29 Dec 2014 New trial record
17 Nov 2014 According to an Organic Vaccines media release, the company is completing the necessary documentation to file an authorization for compassionate use of its Monoclonal Antibodies from the WHO.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com